The need for better antifungal therapy is commonly accepted in view of the high mortality
rates associated with systemic infections, the low number of available antifungal classes …

Fungal infections include a wide range of opportunistic and invasive diseases. Two of four
major fatal diseases in patients with human immunodeficiency virus (HIV) infection are …

Paracoccidioidomicose é a mais prevalente micose sistêmica na América Latina, em
pacientes imunocompetentes, sendo causada pelo fungo dimórfico Paracoccidioiddes …

After viruses and bacteria, fungal infections remain a serious threat to the survival and well-
being of society. The continuous emergence of resistance against commonly used anti …

Fungal infections represent a serious global health problem, causing damage to health and
the economy on the scale of millions. Although vaccines are the most effective therapeutic …

The development of biocompatible polymeric nanoparticles has become an important
strategy for optimizing the therapeutic efficacy of many classical drugs, as it may expand …

The finding that some mAbs are antifungal suggests that antibody immunity may play a key
role in the defense of the host against mycotic infections. The discovery of antibodies that …

Paracoccidioidomycosis (PCM) is a granulomatous fungal disease caused by the dimorphic
fungal species of Paracoccidioides, which mainly affects the lungs. Modern strategies for the …

Fungal organisms are ubiquitous in the environment. Pathogenic fungi, although relatively
few in the whole gamut of microbial pathogens, are able to cause disease with varying …

Paracoccidioidomycosis (PCM) is an endemic Latin American mycosis caused by
Paracoccidioides brasiliensis and also by the recently described P. lutzii. The systemic …